Carregando...
Lichenoid drug eruption due to imatinib mesylate
Imatinib mesylate is a selective tyrosinase kinase inhibitor which has revolutionized the treatment of chronic myeloid leukemia. It is also used in gastrointestinal stromal tumors and dermatofibrosarcoma protruberans. Cutaneous adverse reactions are the most common nonhematological side effects seco...
Na minha lista:
| Publicado no: | Int J Appl Basic Med Res |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4318107/ https://ncbi.nlm.nih.gov/pubmed/25664274 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-516X.149253 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|